Guangdong Marubi Biotechnology Hits Day Low Amid Price Pressure at CNY 29.27

Guangdong Marubi Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 3.08% on July 10, 2026. The stock reached an intraday low of CNY 29.27, reflecting ongoing challenges in its market performance. Over the past year, the company has faced a significant downturn, with a return of -28.45%, contrasting sharply with the China Shanghai Composite's gain of 13.86% during the same period. Despite a recent uptick of 1.34% over the past week and a substantial 35.12% increase in the last month, the long-term outlook remains concerning. The company's net sales have grown at an annual rate of 14.97%, but operating profit has declined by 6.64% over the last five years. The return on equity stands at 10.47%, and the stock currently has a price-to-book ratio of 4.68, indicating a high valuation relative to its book value. With a market capitalization of CNY 8,934 million, Guangdong Marubi operates within the FMCG sector, but its performance metrics suggest a consistent underperformance against market benchmarks.